Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE approves first biliary cholangitis drug in 20 years

March 2, 2017
Sales and Marketing Intercept Pharmaceuticals, intercept, liver disease, ocaliva, primary biliary cholangitis

Intercept Pharmaceuticals has announced that Ocaliva (obeticholic acid) has been approved by the National Institute for Health and Care Excellence …

News
x-ray-1704854_960_720

Osteoporosis drugs potentially causing long-term bone weakness

March 2, 2017
Research and Development osteoporosis

Medication that is used to treat those suffering from weakened bones may actually be causing further damage, new research from …

News
images

Roche’s neoadjuvant breast cancer combo therapy shows strong Phase 3 results

March 2, 2017
Research and Development Herceptin, Perjeta, Roche

Roche’s combination treatment of Perjeta (pertuzumab), Herceptin (trasdtuzumab) and chemotherapy met its primary endpoint in a recent Phase 3 study. …

News
novartis_headquarters

South Korea fines Novartis over kickbacks scandal

March 2, 2017
Medical Communications, Sales and Marketing Kickback, Novartis, south korea

South Korea’s Ministry of Food and Drug Safety has fined Novartis 200 million won ($174,936) over the payment of kickbacks …

News
scott_smith_252

New COO for Celgene

March 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …

Appointment

Pfizer plant receives FDA warning letter for contamination of medicine

March 1, 2017
Manufacturing and Production Copaxone, Mylan, Pfizer, Teva, generics

The FDA has issued a warning letter to Pfizer after inspectors discovered that the plant did not protect properly against …

News

Graham Dunkley chooses Medica’s Pharma Cartons

March 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medica Packaging

Medica Packaging is pleased to announce that Graham Dunkley, most recently of Multi Packaging Solutions (MPS) has joined Medica as …

News
Press release
800px-cocainehydrochloridepowder

Promising anti-cocaine treatment aims for human trials within a year

March 1, 2017
Research and Development University of Cincinnati, cocaine, immunotherapy

Researchers at the University of Cincinnati (UC) have developed a monocloncal antibody designed to treat cocaine addiction; its successful showing …

News
lungs

Asthma drugs may have alternative function as pneumonia treatment

March 1, 2017
Research and Development asthma, influenza, pneumonia

Researchers from the University of Virginia School of Medicine have discovered that two drugs commonly used to treat asthma, Accolate …

News
kitepharma_fullcolor_rgb_1

Kite Pharma climbs on strong data showing in lymphoma trial

March 1, 2017
Research and Development kite pharma, non-Hodgkin lymphoma

Kite Pharma released the news on Rare Diseases Day promising top-line data from a Phase 1/2 trial of its treatment …

News
jakob-riis

Novo Nordisk’s Head of North America resigns

March 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment

Novo Nordisk has announced the surprising news that its Executive Vice President, Head of North American Operations Jakob Riis has …

News
keytruda1

NICE knocks back MSD’s Keytruda for lung cancer indication

February 28, 2017
Research and Development, Sales and Marketing MSD, NICE, NSCLC, keytruda

MSD’s immunotherapy drug Keytruda (pembrolizumab) has been knocked back by the National Institute of Health and Care Excellence (NICE) for …

News
world_health_organization_flag

WHO releases list of bacteria that pose greatest threat to humankind

February 28, 2017
Research and Development WHO, antibiotic resistance

The World Health Organisation (WHO) has published a list of the 12 bacteria that are thought to present the largest …

News

FDA green lights AstraZeneca type-2 diabetes drug

February 28, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA

AstraZeneca has announced that its type-2 diabetes treatment Qtern (10mg dapagliflozin and 5mg saxagliptin) has received the approval of the …

News
jj_2johnson_and_johnson

J&J latest pharma firm to volunteer pricing data

February 28, 2017
Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson

Johnson & Johnson released its pricing data, as promised, in February and it has simply revealed that its average price …

News

Sanofi and Lonza partner up for €270m biologics facility

February 28, 2017
Manufacturing and Production Lonza, Sanofi

Sanofi and Lonza have announced they are to join forces in a strategic partnership which will see the establishment of …

News
14171731710_ff2df4d112_o

Huge data loss puts NHS privatisation and Health Secretary under pressure

February 28, 2017
Manufacturing and Production Jeremy Hunt, NHS, data

It has been revealed that a private company, responsible for delivering NHS data, accidentally stored 708,000 pieces of patient data …

News
janssen_latest_logo_on_sign_closer

EMA recommends expanded indication for Janssen multiple myeloma drug

February 27, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Janssen, darzalex

The European Medicines Agency’s Committee for Medicinal Products for Human Use has given its positive opinion for the use of …

News
lajolla-pharmaceutical-company-ljpc-stock-news

La Jolla finds potential jewel in successful Phase 3 trial

February 27, 2017
Manufacturing and Production, Research and Development La Jolla pharmaceutical

La Jolla Pharmaceutical, a biotech company based in San Diego, US, received a boost to both its shares and its …

News
c5rxfeiwyaez8kv

Moderna Therapeutics instates MIT Treasurer to Board of Directors

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MIT, Moderna, Moderna Therapeutics

Moderna Therapeutics, a clinical stage biotechnology company, has announced the appointment of Israel Ruiz to the company’s Board of Directors. …

Appointment
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026